Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Re Joint Venture

12 Aug 2009 09:24

RNS Number : 3017X
Compagnie de Saint-Gobain
12 August 2009
 



August 12, 2009

Saint-Gobain steps up its growth in renewable energy with an increased participation in Avancis

As part of its development strategy for solar energy, Saint-Gobain is acquiring Shell's share of Avancis, a joint venture between the two companies. 

Avancis has developed highly competitive technology for thin-film CIS (Copper, Indium and Selenide) to manufacture photovoltaic modules. With an annual capacity of 20 megawatts, the company's first plant is already operating in Torgau, Germany. This extremely promising technology necessitates expertise in glass coating and in glass thermal treatment, two processes belonging to the core portfolio of Saint-Gobain, a worldwide leader in flat glass for the building and automotive industries.

Saint-Gobain intends to accelerate the industrial development of Avancis.

Saint-Gobain provides a vast range of products and services in solar energy via Saint-Gobain Solar, its new entity which groups all of Saint-Gobain's solar businesses. Present across the whole value chain, Saint-Gobain Solar's strategy hinges on three independent activities: 

The making and selling of high-tech components for PV modules (special glass, performance plastics, etc.) and high-performance mirrors for solar thermal plant operators.

The production by its Avancis company of thin-film PV modules using CIS (Copper, Indium, Selenide) technology, for distributors and integrators.

The design and marketing of PV solutions for residential homes, offices, industrial installations and farm buildings.

Analyst & Investor Relations

Press Relations

Florence Triou-Teixeira +33 1 47 62 45 19

Etienne Humbert +33 1 47 62 30 49

Vivien Dardel  +33 1 47 62 44 29

Sophie Chevallon +33 1 47 62 30 48

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
JVEVLLBFKVBLBBX
Date   Source Headline
25th Feb 20165:10 pmRNSAnnual Results
19th Jan 20167:57 amRNSJV announcement
13th Jan 20168:19 amRNSNew capacity
5th Jan 20165:18 pmRNSAcquisition
4th Jan 20164:50 pmRNSAcquisition
7th Dec 201512:48 pmRNSAcquisition
26th Nov 20156:29 pmRNSShares cancellation
30th Oct 20159:27 amRNSDisposal
29th Oct 20154:58 pmRNSDisposal
28th Oct 20155:16 pmRNS3rd Quarter Results
7th Oct 20154:54 pmRNSDisposal
5th Oct 20154:53 pmRNSCancellation of shares
16th Sep 20157:00 amRNSAcquisition
15th Sep 20157:59 amRNSDisposal
2nd Sep 20157:00 amRNSAcquisition
1st Sep 20157:02 amRNSProspectus Supplement
27th Aug 20155:56 pmRNSHalf Yearly Report
29th Jul 20155:02 pmRNSHalf Yearly Report
29th Jul 20157:51 amRNSSaint-Gobain reinforces its Gypsum business in US
28th Jul 201510:44 amRNSAcquisition
27th Jul 20157:40 amRNSAcquisition
23rd Jul 201512:03 pmRNSAcquisition
20th Jul 20155:02 pmRNSRe Joint Venture
17th Jul 20155:50 pmRNSPublication of Prospectus
1st Jul 20155:10 pmRNS2014 Dividend
8th Jun 20157:08 amRNSDisposal
5th Jun 20159:33 amRNSAGM Statement
1st Jun 20154:51 pmRNSAcquisition
6th May 20154:46 pmRNSAcquisition
5th May 20157:01 amRNSAcquisition
28th Apr 20155:02 pmRNS1st Quarter Results
15th Apr 20157:00 amRNSAcquisition
14th Apr 20158:41 amRNSAcquisition
7th Apr 20154:55 pmRNSAcquisition
2nd Apr 20155:40 pmRNSFinal Terms
1st Apr 20156:28 pmRNSAcquisition
4th Mar 201512:06 pmRNSProspectus Supplement
25th Feb 20155:15 pmRNSAnnual Results
10th Feb 20157:52 amRNSDisposal
26th Jan 20159:15 amRNSAcquisition
16th Jan 20154:45 pmRNSAcquisition
15th Jan 201511:46 amRNSAcquisition
23rd Dec 20142:32 pmRNSFinal Terms
8th Dec 20147:04 amRNSAcquisition
1st Dec 20144:51 pmRNS2 Directors representing employees at Saint-Gobain
27th Nov 20145:31 pmRNSSaint-Gobain to cancel 6.1 million shares
29th Oct 20144:45 pmRNSNew plant
27th Oct 20144:58 pmRNSNew plant
27th Oct 20147:56 amRNSAcquisition
23rd Oct 20144:46 pmRNS3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.